AHA files amicus brief in 4th Circuit in support of Maryland 340B contract pharmacy law
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to affirm a decision by the U.S. District Court for the District of Maryland in September to deny a preliminary injunction sought by drug companies and PhRMA against enforcement of Maryland's state law protecting 340B pricing for contract pharmacy arrangements.
The AHA also filed amicus briefs in the district court in July and August, defending Maryland’s law against drug industry efforts to enjoin it.
Others joining AHA in the Feb. 28 filing were 340B Health, the Maryland Hospital Association, the Mid-Atlantic Association of Community Health Centers and the American Society of Health-System Pharmacists.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…
Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program. “When…
Blog
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4…
Headline
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In…
Headline
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District…